A detailed history of Two Sigma Investments, LP transactions in Cerus Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 595,234 shares of CERS stock, worth $982,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
595,234
Previous 268,629 121.58%
Holding current value
$982,136
Previous $467,000 96.15%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.52 - $2.03 $496,439 - $663,008
326,605 Added 121.58%
595,234 $916,000
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.39 $212,284 - $298,446
124,873 Added 86.86%
268,629 $467,000
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.04 $232,884 - $293,262
143,756 New
143,756 $253,000
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $248,067 - $466,366
198,454 Added 148.84%
331,790 $716,000
Q3 2023

Nov 14, 2023

BUY
$1.5 - $3.07 $200,004 - $409,341
133,336 New
133,336 $216,000
Q2 2022

Aug 15, 2022

SELL
$4.41 - $5.69 $1.33 Million - $1.72 Million
-301,780 Reduced 63.48%
173,632 $919,000
Q1 2022

May 16, 2022

SELL
$4.81 - $6.99 $451,495 - $656,123
-93,866 Reduced 16.49%
475,412 $2.61 Million
Q4 2021

Feb 14, 2022

SELL
$5.97 - $7.93 $699,319 - $928,912
-117,139 Reduced 17.07%
569,278 $3.88 Million
Q3 2021

Nov 15, 2021

SELL
$4.79 - $6.68 $856,480 - $1.19 Million
-178,806 Reduced 20.67%
686,417 $4.18 Million
Q2 2021

Aug 16, 2021

BUY
$5.35 - $6.35 $2.62 Million - $3.11 Million
490,271 Added 130.76%
865,223 $5.11 Million
Q1 2021

May 17, 2021

BUY
$5.68 - $7.87 $1.31 Million - $1.81 Million
230,429 Added 159.44%
374,952 $2.25 Million
Q4 2020

Feb 16, 2021

SELL
$5.25 - $8.56 $267,734 - $436,534
-50,997 Reduced 26.08%
144,523 $1 Million
Q3 2020

Nov 16, 2020

BUY
$5.78 - $7.47 $267,070 - $345,158
46,206 Added 30.95%
195,520 $1.22 Million
Q2 2020

Aug 14, 2020

BUY
$4.5 - $7.02 $421,051 - $656,840
93,567 Added 167.84%
149,314 $985,000
Q1 2020

May 15, 2020

SELL
$2.87 - $5.49 $751,400 - $1.44 Million
-261,812 Reduced 82.45%
55,747 $259,000
Q4 2019

Feb 14, 2020

BUY
$3.84 - $4.86 $1.22 Million - $1.54 Million
317,559 New
317,559 $1.34 Million
Q2 2019

Aug 14, 2019

SELL
$4.51 - $6.6 $222,221 - $325,201
-49,273 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$5.16 - $6.85 $200,822 - $266,595
38,919 Added 375.88%
49,273 $307,000
Q4 2018

Feb 14, 2019

SELL
$4.89 - $7.16 $1.44 Million - $2.11 Million
-295,051 Reduced 96.61%
10,354 $52,000
Q3 2018

Nov 14, 2018

BUY
$6.89 - $7.78 $1.26 Million - $1.42 Million
182,214 Added 147.91%
305,405 $2.2 Million
Q2 2018

Aug 14, 2018

SELL
$5.19 - $7.25 $505,573 - $706,244
-97,413 Reduced 44.16%
123,191 $822,000
Q1 2018

May 15, 2018

BUY
$3.56 - $5.74 $523,512 - $844,089
147,054 Added 199.94%
220,604 $1.21 Million
Q4 2017

Feb 14, 2018

BUY
$2.76 - $3.95 $202,997 - $290,522
73,550
73,550 $249,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $292M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.